Tumor-specific cytotoxicity and type of cell death induced by sodium 5,6-benzylidene-L-ascorbate

Anticancer Research

Volumn 28, Issue 5 A, 2008, Pages 2577-2584

  Kishino, Kaori ^a   Hashimoto, Ken ^a   Amano, Osamu ^a   Kochi, Mutsuyuki ^b   Liu, W K ^c   Sakagami, Hiroshi ^a  

^a MEIKAI UNIVERSITY SCHOOL OF DENTISTRY   (Japan)

^b Ichijokai Hospital   (Japan)

^c and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

Apoptosis; Autophagy; Benzylidene ascorbate; Tumor specificity; Type of cell death

Indexed keywords

5,6 BENZYLIDENEASCORBIC ACID; CASPASE 3; CASPASE 8; CASPASE 9; DACTINOMYCIN;

ACIDITY; ARTICLE; AUTOPHAGY; CANCER CELL CULTURE; CELL DEATH; CELL ORGANELLE; CONTROLLED STUDY; CYTOTOXICITY; DNA FRAGMENTATION; ELECTRON MICROSCOPY; FIBROBLAST; GLIOBLASTOMA; HUMAN; HUMAN CELL; INCUBATION TIME; LEUKEMIA CELL LINE; MITOCHONDRIAL MEMBRANE; PERIODONTAL LIGAMENT; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; STAINING; STARVATION;

ANTINEOPLASTIC AGENTS; ASCORBIC ACID; BENZYLIDENE COMPOUNDS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; DRUG SCREENING ASSAYS, ANTITUMOR; FIBROBLASTS; GLIOBLASTOMA; HL-60 CELLS; HUMANS; LEUKEMIA, MYELOID; MOUTH NEOPLASMS;

EID: 55749099829     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Kochi M: Manufacturing Process of Anticancer Substance. Japanese Patent, No. 560349, 1969.
2. Takeuchi S, Kochi M, Sakaguchi K, Nakagawa K and Mizutani T: Benzaldehyde as a carcinostatic principle in figs. Agric Biol Chem 42: 1449-1451, 1978.
3. Kochi M, Isono N and Niwayama M: Antitumor activity of benzaldehyde derivatives. The 13th International Cancer Congress, Seattle, 1982.
4. Kochi M and Kobayashi K: Antitumor activity of benzaldehyde derivatives. Particularly with regards to 5,6-O-benzylidene-L-ascorbic acid sodium salt. The 14th International Cancer Congress, Budapest, 1986.
5. Kochi M, Takeuchi S, Mizutani T, Mochizuki K, Matsumoto Y and Saito Y: Antitumor activity of benzaldehyde. Cancer Treat Rep 64: 21-23, 1980.
6. Kochi M, Ueda S and Hagiwara T: Antitumor activity of sodium benzylideneascorbate. In: Progress in Cancer Research and Therapy. Bresciani F, King RJB, Lippman ME and Raynaud JP (eds.). Vol 35: Hormones and Cancer 3, New York, Raven Press, Ltd. pp. 338-343, 1988.
7. Tatsumura T, Tsujimoto M, Koyams S, Furuno T, Komori Y, Sato H, Yamamoto K, Kitagawa M and Kagamimori S: 4, 6-O-benzilidene-D-glucopyranose (BG) in the treatment of solid malignant tumors, and extended phase I study. Br J Cancer 62: 436-439, 1990.
8. Sakagami H, Asano K, Fukuchi K, Gomi K, Ota H, Kazama K, Tanuma S and Kochi M: Induction of tumor degeneration by sodium benzylidene ascorbate. Anticancer Res 11: 1533-1538, 1991.
9. Sakagami H, Takeda M, Utsumi A, Fujinaga S, Tsunoda A, Yasuda N, Shibusawa M, Koike T, Ota H, Kazama K, Shiokawa D, Tanuma S and Kochi M: Effect of sodium benzylidene-ascorbate on chemically-induced tumors in rats. Anticancer Res 13: 65-72, 1993.
10. 2H) on cis-diamminedichloroplatinum (II)-induced cytotoxicity. Anticancer Res 12: 33-38, 1992.
11. Tajima M, Toguchi M, Kanda S, Kunii S, Hosaka M, Arakawa H, Maeda M, Satoh K, Asano K, Kochi M and Sakagami HH: Role of hydrogen peroxide for cell death induction by sodium 5,6-benzylidene-L-ascorbate. Anticancer Res 18: 1697-1702, 1998.
12. Fujii H, Amano O, Kochi M and Sakagami H: Mitochondrial control of cell death induction by sodium 5,6-benzylidene-L-ascorbate. Anticancer Res 23: 1353-1356, 2003.
13. Liu Y, Sakagami H, Hashimoto K, Kikuchi H, Amano O, Ishihara M, Kanda Y, Kunii S, Kochi M, Zhang W and Yu G: Tumor-specific cytotoxicity and type of cell death induced by β-cyclodextrin benzaldehyde inclusion compound. Anticancer Res 28: 229-236, 2008.
14. Broker LE, Kruyt FAE and Giaccone G: Cell death independent of caspase: A review. Clin Cancer Res 11: 3155-3162, 2005.
15. Derbnath J, Baehrecke EH and Kroemer G: Does autophagy contribute to cell death? Autophagy 1: 66-74, 2005.
16. Satoh R, Kishino K, Morshed SRM, Takayama F, Otsuki S, Suzuki F, Hashimoto K, Kikuchi H, Nishikawa H, Yasui T and Sakagmi H: Changes in fluoride sensitivity during in vitro senescence of human normal oral cells. Anticancer Res 25: 2085-2092, 2005.
17. Yanagisawa-Shiota F, Sakagami H, Kuribayashi N, Iida M, Sakagami T and Takeda M: Endonuclease activity and induction of DNA fragmentation in human myelogenous leukemic cell lines. Anticancer Res 15: 259-266, 1995.
18. Sekine T, Takahashi J, Nishishior M, Arai A, Wakabayashi H, Kurihara T, Kobayashi M, Hashimoto K, Kikuchi H, Katayama T, Kanda Y, Kunii S, Motohashi N and Sakagami H: Tumor-specificity and type of cell death induced by trihaloacetylazulenes in human tumor cell lines. Anticancer Res 27: 133-144, 2007.
19. Dunn WA Jr: Autophagy and related mechanisms of lysosome-mediated protein degradation. Trends Cell Biol 4: 139-143, 1994.
20. Jin S: Autophagy, mitochondria quality control, and oncogenesis. Autophagy 2: 80-84, 2006.
21. Hashimoto K and Sakagami H: Induction of apoptosis by epigallocatechin gallate and autophagy inhibitors in a mouse macrophage-like cell line. Anticancer Res 28: 1713-1718, 2008
22. Cui Q, Tashiro S, Onodera S and Ikejima T: Augmentation of oridonin-induced apoptosis observed with reduced autophagy. J Pharmacol Sci 101: 230-239, 2006.
23. Sakagami H, Kawase M, Wakabayashi H and Kurihara T: Factors that affect the type of cell death induced by chemicals. Autophagy 3: 493-495, 2007.
24. Suzuki F, Hashimoto K, Kikuchi H, Nishikawa H, Matsumoto H, Shimada J, Kawase M, Sunaga K, Tsuda T, Satoh K and Sakagami H: Induction of tumor-specific cytotoxicity and apoptosis by doxorubicin. Anticancer Res 25: 887-894, 2005.
25. Sasaki M, Okamura M, Ideo A, Shimada J, Suzuki F, Ishihara M, Kikuchi H, Kanda Y, Kunii S and Sakagami H: Re-evaluation of tumor-specific cytotoxicity of mitomycin C, bleomycin and peplomycin. Anticancer Res 26: 3373-3380, 2006.
26. Das U, Kawase M, Sakagami H, Ideo A, Shimada J, Molnar J, Barath Z, Bata Z and Dimmock JR: 3-(3,4,5-Trimethoxyphenyl)-1-oxo-2-propene: A novel pharmacophore displaying potent multidrug resistance reversal and selective cytotoxicity. Bioorg Med Chem 15: 3373-3380, 2007.
27. Sakagami H, Sakagami T, Takeda M, Iwaki K and Takeda M: Determination of sodium 5,6-benzylidene-L-ascorbate and related compounds by high-performance liquid chromatography. J Chrom 653: 37-43, 1993.
28. Sakagami H, Sakagami T, Yamamura M, Takahashi H, Shibuya I and Takeda M: Stability of sodium 5,6-benzylidene-L-ascorbate. Anticancer Res 15: 1269-1274, 1995.